# FDA 483 - Martin Kankam - December 16, 2016

Source: https://www.globalkeysolutions.net/records/483/martin-kankam/84d80238-7874-4709-9fa0-112607189515

> FDA 483 for Martin Kankam on December 16, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Martin Kankam
- Inspection Date: 2016-12-16
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: An FDA inspection of Martin Kankam, a clinical investigator in Overland Park, Kansas, revealed a significant issue with a clinical study. The firm failed to conduct an investigation in accordance with the investigational plan, specifically regarding incorrect dosing of subjects in a drug immunogenicity study. This indicates a serious deviation from study protocol.

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)

Company: https://www.globalkeysolutions.net/companies/martin-kankam/38e98d0b-bed2-439e-aa4f-52aef5345e40

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8